Literature DB >> 27411578

Molecular Subtypes of Non-muscle Invasive Bladder Cancer.

Seth P Lerner1, A Gordon Robertson2.   

Abstract

In this issue of Cancer Cell, Hedegaard et al. report a comprehensive multi-center transcriptional analysis of non-muscle invasive urothelial bladder cancer. They describe three molecular subtypes similar to those seen in other cohorts, as well as a unique CIS signature associated with risk of progression to muscle invasive cancer.
Copyright © 2016. Published by Elsevier Inc.

Entities:  

Mesh：

Year:  2016        PMID： 27411578     DOI： 10.1016/j.ccell.2016.06.012

Source DB:  PubMed          Journal:  Cancer Cell        ISSN： 1535-6108            Impact factor:   31.743


  8 in total

Review 1.  Molecularly-driven precision medicine for advanced bladder cancer.

Authors:  Laura-Maria Krabbe; Vitaly Margulis; Andres Jan Schrader; Shahrokh F Shariat; Kilian M Gust; Martin Boegemann
Journal:  World J Urol       Date:  2018-06-08       Impact factor: 4.226

2.  Long Noncoding RNA SNHG1 Activates Autophagy and Promotes Cell Invasion in Bladder Cancer.

Authors:  Changcheng Guo; Xin Li; Jinbo Xie; Dan Liu; Jiang Geng; Lin Ye; Yang Yan; Xudong Yao; Ming Luo
Journal:  Front Oncol       Date:  2021-05-13       Impact factor: 6.244

Review 3.  Ten Years of Proteomics in Bladder Cancer: Progress and Future Directions.

Authors:  Maria Frantzi; Antonia Vlahou
Journal:  Bladder Cancer       Date:  2017-01-27

4.  Proceedings of the 3rd Annual Albert Institute for Bladder Cancer Research Symposium.

Authors:  Thomas W Flaig; Ashish M Kamat; Donna Hansel; Molly A Ingersoll; H Barton Grossman; Cathy Mendelsohn; David DeGraff; Joseph C Liao; John A Taylor
Journal:  Bladder Cancer       Date:  2017-07-27

5.  Whole-genome sequencing identifies ADGRG6 enhancer mutations and FRS2 duplications as angiogenesis-related drivers in bladder cancer.

Authors:  Song Wu; Tong Ou; Nianzeng Xing; Jiang Lu; Shengqing Wan; Changxi Wang; Xi Zhang; Feiya Yang; Yi Huang; Zhiming Cai
Journal:  Nat Commun       Date:  2019-02-12       Impact factor: 14.919

6.  Development and Validation of a Novel Recurrence Risk Stratification for Initial Non-Muscle Invasive Bladder Cancer in the Han Chinese Population.

Authors:  Zhiyong Wang; Wansheng Gao; Jian Li; Tianen Wang; Man Zhu; Yu Duan
Journal:  J Cancer       Date:  2020-01-14       Impact factor: 4.207

7.  Tumor Microenvironment Analysis Identified Subtypes Associated With the Prognosis and the Tumor Response to Immunotherapy in Bladder Cancer.

Authors:  Hongxian Zhang; Jiwen Song; Junqiang Dong; Zhuo Liu; Lixuan Lin; Bing Wang; Qiang Ma; Lulin Ma
Journal:  Front Genet       Date:  2021-03-01       Impact factor: 4.599

8.  Practicability of clinical application of bladder cancer molecular classification and additional value of epithelial-to-mesenchymal transition: prognostic value of vimentin expression.

Authors:  João Lobo; Sara Monteiro-Reis; Catarina Guimarães-Teixeira; Paula Lopes; Isa Carneiro; Carmen Jerónimo; Rui Henrique
Journal:  J Transl Med       Date:  2020-08-05       Impact factor: 5.531
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.